Senores Pharmaceuticals Ltd Share Price

Pharmaceuticals

NSE: SENORES Small Cap ISIN: INE0RB801010

As on 13 June 2026 at 02:33 IST

₹1,192.40

+ 31.70

(2.73%)

Sell Buy

Over 1 Month

21.18%

Over 6 Months

51.99%

Over 1 Year

114.11%

Over 3 Years

None%

Senores Pharmaceuticals Ltd Summary

Close ₹1,160.70

Open ₹1,126.20

High ₹1,194.90

Low ₹1,115.40

Volume 7,80,945

Net Turnover (in Cr) ₹91.46

52Wk High ₹1,194.90

52Wk Low ₹513

52Wk High / Low

513

1,194.90

Senores Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹5,345.44

EPS (TTM) 4.40

Book Value (BV) 162.83

Div. Yield -

P/E (TTM) 263.55

Price/Book Value 7.12

Delivery % 31.69 %

Face Value 10

Key Ratios

PE Ratio 715.94

PB Ratio 3.73

EV to Sales 61.77

PEG Ratio 3.65

ROA 0.45

ROE 0.84

Debt-Equity 0.23

Net Profit Margin 9.57

Operating Profit Margin 38.17

Senores Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	417.51	217.34	39.02	14.63
Total Expenses	346.94	192.40	26.58	13.49
Profit Before Tax	70.57	24.94	12.44	1.14
Profit After Tax	58.34	32.71	8.43	0.99
Operating Profit After Depreciation	92.12	34.39	14.57	1.71

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Fixed Assets	429.02	314.75	53.65	14.61
Total Non Current Assets	504.43	370.97	79.72	32.10
Total Current Assets	722.43	250.91	51.34	27.05
Total Assets	1,226.86	621.88	131.05	59.15
Total Shareholder's Fund	786.18	204.27	45.50	36.59

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash From Operating Activities	-45.92	-25.70	-1.08	-10.45
Net Cash Used In Investing Activities	-429.48	-53.73	-48.29	-24.44
Net Cash Used In Financing Activities	573.13	86.98	46.25	36.46

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	60.53	40.85	19.17	14.48	8.06
Total Expenses	55.42	38.82	17.23	13.65	7.66
Profit Before Tax	5.11	2.03	1.94	0.83	0.40
Profit After Tax	3.69	0.81	1.20	0.68	0.84
Operating Profit After Depreciation	11.63	4.74	4.08	1.39	0.60

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	54.59	27.68	11.05	4.76	4.41
Total Non Current Assets	422.02	245.90	84.04	41.19	6.76
Total Current Assets	412.07	39.96	27.68	13.98	8.20
Total Assets	834.09	285.86	111.72	55.17	14.96
Total Shareholder's Fund	707.97	168.12	38.92	33.69	9.47

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-20.40	-19.26	-43.41	-24.06	-2.87
Net Cash Used In Investing Activities	-162.94	-57.07	-5.23	-10.05	-4.37
Net Cash Used In Financing Activities	532.62	86.68	47.08	33.88	8.50

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	175.19	170.95	161.76	137.99	114.21
Total Expenses	127.70	120.55	112.25	103.83	94.77
Profit Before Tax	47.40	44.60	40.64	26.49	20.68
Profit After Tax	36.67	33.58	30.12	21.18	17.97
Operating Profit after Depreciation	65.16	57.79	54.92	37.52	31.21

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	36.81	25.15	35.33	19.82	11.86
Total Expenses	40.29	29.69	33.81	20.98	14.60
Profit Before Tax	12.69	3.51	7.65	3.59	2.89
Profit After Tax	8.48	2.65	6.43	2.70	2.01
Operating Profit after Depreciation	18.71	8.84	12.88	7.23	6.51

Senores Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,119.10

S2 1,077.50

S3 1,039.60

Pivot 1,157

R1 1,198.60

R2 1,236.50

R3 1,278.10

Moving Average

20 SMA 1,081.91

50 SMA 955.49

100 SMA 869.08

200 SMA 814.35

Senores Pharmaceuticals Ltd Corporate Actions

No available data

Senores Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Senores Pharmaceuticals Ltd Top Mutal Funds Invested

Fund Name	AUM
Mahindra Manulife Large & Mid Cap Fund	2.08%
Mahindra Manulife Balanced Advantage Fund	1.36%
WhiteOak Capital Pharma and Healthcare Fund	0.85%
Bajaj Finserv Healthcare Fund	0.84%
HSBC Multi Cap Fund	0.49%

Senores Pharmaceuticals Ltd News

Senores Pharmaceuticals to hold board meeting

On 14 May 2026

09 May 2026, 11:25 am

Senores enters into US government procurement market

Forms JV named Amerisyn to participate in government supply tenders

04 Apr 2026, 11:30 am

Senores Pharma slumps as Q3 PAT slides 2% QoQ to Rs 32 cr

Shares of Senores Pharmaceuticals tanked 5.50% to Rs 762.15 due to weak sequential performance.

20 Jan 2026, 02:42 pm

Senores Pharmaceuticals to hold board meeting

On 20 January 2026

14 Jan 2026, 10:17 am

Senores Pharmaceuticals EGM scheduled

On 31 January 2026

08 Jan 2026, 04:36 pm

Senores Pharmaceuticals Ltd Stock Analysis

Annual revenue for Senores Pharmaceuticals Ltd increased by 48.18% to ₹60.53 crore in FY 2025 from ₹40.85 crore in FY 2024.
Annual Net Profit for Senores Pharmaceuticals Ltd increased by 355.56% to ₹3.69 crore in FY 2025 from ₹0.81 crore in FY 2024.
Promoter Shareholding in Senores Pharmaceuticals Ltd increased by 0.03% in the most recent quarter, from 45.80% in December 2025 to 45.82% in March 2026.
Senores Pharmaceuticals Ltd delivered a 1-year return of 114.11% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Senores Pharmaceuticals Ltd share price moved up by 2.73% from its previous close of INR ₹1,160.70. The latest Senores Pharmaceuticals Ltd share price is INR ₹1,192.40.
Senores Pharmaceuticals Ltd share price today has been at a low of 1,182.80 and a high of 1,215. Over the past 52 weeks, the Senores Pharmaceuticals Ltd share price has seen a low of 513 and a high of 1,215.